We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Learn about Brixadi (buprenorphine) injections for Opioid Use Disorder (OUD), including dosage, strengths, and weekly/monthly administration. Understand its role in recovery and when to consult a doctor.

Opioid Use Disorder (OUD) is a complex and challenging condition that affects millions worldwide. Fortunately, advancements in medical treatment offer hope and effective management strategies. Brixadi, a prescription injection containing buprenorphine, is one such treatment that plays a crucial role in managing OUD in adults. This article delves into the specifics of Brixadi, focusing on its dosage, available strengths, and how it is administered, providing a clear guide for individuals and their caregivers in India.
Brixadi is an extended-release formulation of buprenorphine. This means the medication is slowly released into your body over an extended period, providing consistent therapeutic levels. Buprenorphine itself is a partial opioid agonist. In the context of OUD, it works by binding to the same receptors in the brain that opioids do, but with a weaker effect. This helps to reduce cravings and withdrawal symptoms associated with opioid cessation, without producing the same euphoric high as full opioid agonists. It is an integral part of a comprehensive treatment program that typically includes counseling and psychotherapy to address the psychological and social aspects of addiction.
Brixadi is specifically prescribed for adults diagnosed with moderate to severe Opioid Use Disorder. It is generally considered for individuals who have been stable on other forms of buprenorphine treatment or who have undergone a test dose to ensure they do not experience significant withdrawal symptoms.
A key feature of Brixadi is its flexible administration schedule, offered as either weekly or monthly injections. The choice between these schedules is determined by your healthcare provider based on your individual needs, response to treatment, and previous buprenorphine experience.
Weekly injections are typically prescribed for individuals who:
The usual maintenance dosage for weekly injections ranges from 24 mg per week to a maximum of 32 mg per week. The injections are administered every 7 days.
Monthly injections may be prescribed for individuals who have been on a stable dose of buprenorphine SLT for a significant period. The usual maintenance dosage for monthly injections ranges from 96 mg per month to a maximum of 128 mg per month. These injections are administered every 28 days.
Brixadi is available in prefilled syringes, making administration straightforward for healthcare professionals. The strengths are measured in milligrams (mg) of buprenorphine per milliliter (mL) of liquid solution. The specific strengths available depend on whether it is for weekly or monthly administration:
Your doctor will select the appropriate strength and dosage to meet your specific treatment requirements.
The decision regarding the optimal dosage and administration schedule for Brixadi rests with your doctor. This personalized approach considers several factors:
It is crucial to adhere strictly to the prescribed dosage and schedule. Missing an appointment for your injection can disrupt the steady levels of medication in your body, potentially impacting treatment effectiveness. If you miss an appointment, contact your doctor's office immediately to reschedule.
In some instances, your doctor may decide to switch your treatment from a weekly to a monthly schedule, or vice versa. The dosage will be adjusted accordingly to ensure a smooth transition and continued therapeutic benefit. Your doctor will provide specific guidance on how this transition will occur.
Brixadi is typically intended for long-term treatment of OUD. If your doctor determines that it is safe and effective for your condition, you may continue receiving Brixadi injections for an extended period. Regular monitoring by your healthcare provider is essential throughout your treatment. They will assess your progress, monitor for any potential side effects, and make necessary dosage adjustments to optimize your treatment outcomes.
Individuals with moderate to severe liver disease require special attention when considering Brixadi. Buprenorphine can accumulate in the body in individuals with impaired liver function, potentially leading to adverse effects. If you have liver disease, your doctor will likely recommend an alternative treatment option or closely monitor you for any signs of complications. If liver problems develop during Brixadi treatment, your doctor may advise you to stop the medication and switch to a safer alternative.
It is essential to maintain open communication with your healthcare provider throughout your Brixadi treatment. You should consult your doctor if:
Brixadi offers a valuable therapeutic option for managing Opioid Use Disorder, providing a pathway towards recovery and improved quality of life. Understanding its administration, dosage, and the importance of consistent medical supervision is key to successful treatment.
Visit Hospital
Near You
Discover advanced paralysis treatment in Supaul. Learn about rehabilitation, therapies, and specialist care for improved recovery and quality of life.
May 19, 2026
Explore paralysis treatment options in Jehanabad. Learn about therapies, specialists, and recovery strategies for enhanced quality of life.
May 19, 2026
Explore paralysis treatment options in Jamalpur. Learn about therapies, rehabilitation, and expert care for recovery and improved quality of life.
May 19, 2026